Immuron (IMRN) Interest Expenses (2017 - 2024)
Immuron (IMRN) recorded quarterly Interest Expenses of -$2.6 billion in Q4 2024, down 65623979.23% quarter-over-quarter from -$4007.0 in Q4 2023, and down 65623979.23% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) Interest Expenses (2017 - 2024) Analysis & Trends
Immuron's Interest Expenses history runs 7 years deep, the most recent figure standing at -$2.6 billion for Q4 2024.
- In Q4 2024, Interest Expenses fell 65623979.23% year-over-year to -$2.6 billion; the TTM figure through Sep 2025 stood at -$2.6 billion (down 65623979.23% YoY), while the FY2025 annual figure was $4734.6, down 4.71% from the prior year.
- Interest Expenses was -$2.6 billion for Q4 2024 at Immuron, down from -$4007.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of -$9.55 in Q4 2021 to a low of -$2.6 billion in Q4 2024.
- Historically, Interest Expenses has averaged -$525.9 million across 5 years, with a median of -$4007.0 in 2023.
- The sharpest annual moves came in 2021 and 2024: Interest Expenses surged 87.98% in 2021, then slumped 65623979.23% in 2024.
- A 5-year view of Interest Expenses shows it stood at -$79.4 in 2020, then soared by 87.98% to -$9.55 in 2021, then slumped by 47053.03% to -$4501.0 in 2022, then gained by 10.98% to -$4007.0 in 2023, then plunged by 65623979.23% to -$2.6 billion in 2024.
- The last three Interest Expenses figures came in at -$2.6 billion (Q4 2024), -$4007.0 (Q4 2023), and -$4501.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.63 Bn |
| Dec 31, 2024 | -2.63 Bn |
| Dec 31, 2023 | -4,007.00 |
| Dec 31, 2023 | -4,007.00 |
| Dec 31, 2022 | -4,501.00 |
| Dec 31, 2022 | -4,501.00 |
| Dec 31, 2021 | -9.55 |
| Dec 31, 2021 | -9.55 |
| Dec 31, 2020 | -79.40 |
| Dec 31, 2020 | -79.40 |
| Dec 31, 2019 | -23.46 |
| Dec 31, 2019 | -23.46 |
| Dec 31, 2017 | -2,935.78 |
| Dec 31, 2017 | -2,935.78 |